Trademark applications and grants for Translational Drug Development, Llc. Translational Drug Development, Llc has 6 trademark applications. The latest application filed is for "THE PRECISION ONCOLOGY CRO"
State Incorporated | DELAWARE |
Entity Type | LIMITED LIABILITY COMPANY |
Address | 13208 East Shea Boulevard, Suite 100 Scottsdale, ARIZONA UNITED STATES 85259 |
Patent Application | Date |
---|---|
METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY AND SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE 20220184040 - 17/598074 Gately; Stephen | 2022-06-16 |
AMINOBENZIMIDAZOLE DERIVATIVES, TREATMENTS, AND METHODS OF INHIBITING HISTONE DEACETYLASE 20220153705 - 17/588945 Wang; Tong ;   et al. | 2022-05-19 |
(S)-N-HYDROXY-2-(2-(4-METHOXYPHENYL)BUTANAMIDO)THIAZOLE-5-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF 20210347747 - 17/344680 Wang; Tong ;   et al. | 2021-11-11 |
BENZAMIDE AND ACTIVE COMPOUND COMPOSITIONS AND METHODS OF USE 20210093717 - 17/110008 Wang; Tong ;   et al. | 2021-04-01 |
AMINOBENZIMIDAZOLE DERIVATIVES, TREATMENTS, AND METHODS OF INHIBITING HISTONE DEACETYLASE 20210061770 - 16/644457 Wang; Tong ;   et al. | 2021-03-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.